FDA Inspection
Comparative Biosciences, IncComparative Biosciences, Inc – FDA Inspection, Apr 10, 2026
Record Details
This FDA Inspection record concerns Comparative Biosciences, Inc, with an inspection on April 10, 2026, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · 400ff501-7b42-4e60-94ba-8c1ed98557cc
Inspection Facts
- Inspection number
- 1312160
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 58.33(c)Study director: unforeseen circumstances
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Comparative Biosciences, Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2024 | VAI | San Francisco District Office | Bioresearch Monitoring |
| May 17, 2019 | VAI | San Francisco District Office | Bioresearch Monitoring |
Other documents for Comparative Biosciences, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.